Speciality Medicines Ltd. (SPML) Share Price Rises 8.11% to Rs 160

Published: 25 September 2026 at 2:48:50 PM IST

Speciality Medicines Share Price rose to Rs 160 today, up 8.11% from the previous close of Rs 148, while market capitalisation stood at Rs 129.59 crore. The move came after the stock opened at Rs 148, touched an intraday low of Rs 148 and finished at the day high of Rs 160, which confirms a full-session move higher in today’s market. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Speciality Medicines Share Price Today, the key takeaway is the combination of the day’s gain, the exact close and the modest turnover of Rs 0.11 crore. In this Speciality Medicines Stock News update, Univest is focusing on what changed in the quote, how the valuation compares with the Trading sector, and what company fundamentals can be verified from the data.

In this Speciality Medicines Share Price story, the company’s current price, day move and market cap make it relevant for Stock Market Today screens, but the evidence should be read as a price rise first and a reason second. Univest notes that no company-specific cause is established in the supplied inputs, so the analysis stays with the verified numbers.

Speciality Medicines Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 160
Previous Close	Rs 148
Today's Move	Rs 12 (+8.11%)
Open	Rs 148
High	Rs 160
Low	Rs 148
Turnover	Rs 0.11 crore
Market Capitalisation	Rs 129.59 crore
Market Cap Category	Micro Cap

Speciality Medicines Ltd. (SPML) rose to Rs 160 from the previous close of Rs 148, a move of Rs 12 or 8.11%. The stock opened at Rs 148, reached a high of Rs 160, recorded a low of Rs 148.

Speciality Medicines Share Price Today ended at Rs 160, adding Rs 12 or 8.11% from the previous close of Rs 148. The day began at Rs 148, traded between Rs 148 and Rs 160, and closed at the high of the day. That sequence shows a clean same-day price rise, with the stock ending above both the open and the prior close. Turnover for the session was Rs 0.11 crore, which is a factual traded-value figure and should be read alongside the day’s quote movement rather than as a signal on its own. Univest classifies this as a notable share price gain within the day’s market action, and the quote data makes Speciality Medicines Share Price one of the more visible Stock Updates in the current session.

Speciality Medicines Ltd. (SPML) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 129.59 crore
P/E Ratio	9.98x
P/B Ratio	1.83x
ROE	37.85%
ROCE	34.47%
EPS	Rs 14.83
Book Value Per Share	Rs 81.03
Dividend Yield	0%

Speciality Medicines Ltd. (SPML) fundamental metrics show P/E 9.98x, P/B 1.83x, ROE 37.85%, ROCE 34.47%. These figures provide context only and are not a buy or sell signal.

Speciality Medicines Ltd. has a market capitalisation of Rs 129.59 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 9.98x, P/B at 1.83x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 37.85% and ROCE of 34.47%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 14.83, book value per share of Rs 81.03, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 23.77x, median ROE of 4.1%, median ROCE of 6.09%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Company P/E Ratio	9.98x
Benchmark Median P/E	23.77x
Benchmark Average P/E	109.87x
Benchmark P/E Range	0.14x to 8,162.7x
Company P/B Ratio	1.83x
Benchmark Median P/B	1.36x
Company ROE	37.85%
Benchmark Median ROE	4.1%
Company ROCE	34.47%
Benchmark Median ROCE	6.09%
Company Market Capitalisation	Rs 129.59 crore
Benchmark Median Market Cap	Rs 52.74 crore

Speciality Medicines Ltd. (SPML) is classified under sector: Trading and industry: Trading.

Speciality Medicines Ltd. (SPML) has a P/E ratio of 9.98x, which is below the benchmark median of 23.77x, a difference of -58.01%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Speciality Medicines Ltd. (SPML) has a ROE of 37.85%, which is above the benchmark median of 4.1%, a difference of +823.17%. Speciality Medicines Ltd. (SPML) has a ROCE of 34.47%, which is above the benchmark median of 6.09%, a difference of +466.01%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Adani Enterprises Ltd.	ADANIENT	4,04,763.06	53.1	4.19	15.07	13.3
Aegis Logistics Ltd.	AEGISLOG	49,336.56	38.41	7.28	20.71	19.76
ADITYA INFOTECH LIMITED	CPPLUS	45,264.11	94.16	22.29	25.68	29.48
Premier Energies Ltd.	PREMIERENE	41,325.48	24.48	8.57	42.6	33.72
Redington Ltd.	REDINGTON	31,353.06	18.68	2.99	13.6	18.96

Speciality Medicines Ltd. (SPML) has a P/E ratio of 9.98x compared with the displayed peer median of 38.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 37.85% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 34.47% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Speciality Medicines Ltd. (SPML) has a market capitalisation of Rs 129.59 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Speciality Medicines

• Speciality Medicines Share Price rose 8.11% today to Rs 160.
• The stock closed at the day high of Rs 160 after opening at Rs 148.
• Market capitalisation stood at Rs 129.59 crore for the latest session.
• P/E is 9.98, while P/B is 1.83 for Speciality Medicines Share Price analysis.
• ROE of 37.85% and ROCE of 34.47% are above the Trading sector median.

About Speciality Medicines Ltd.

Speciality Medicines Ltd. is part of the Trading sector and Trading industry. The supplied data does not break out revenue segments, product mix or business lines, so the company description has to stay limited to what is verified. For that reason, the most reliable company-level context here comes from its market data and financial ratios rather than a broad operating summary. Speciality Medicines Share Price today reflects the market’s latest valuation of the business, while the fundamentals show EPS of Rs 14.83, book value of Rs 81.03 and no dividend yield in the supplied record.

In stock-market terms, Speciality Medicines Stock News is currently tied to the day’s quote movement and the company’s financial metrics. Univest is keeping the explanation factual: the company is presented as a Trading-sector name with a modest market cap, a low single-digit earnings multiple and strong return ratios. That is the cleanest verified description available from the supplied inputs for readers following Speciality Medicines Latest News or Speciality Medicines Share News.

Track Speciality Medicines Share Price on Univest

Use Speciality Medicines Ltd. (SPML) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Speciality Medicines Share Price Today on Univest to review how the latest move fits into the broader company profile, sector context and peer comparison. Univest keeps the focus on verified numbers and clear market context rather than unsupported explanations.

Frequently Asked Questions

Why did Speciality Medicines Share Price rise today?

Ans. The supplied data confirms that Speciality Medicines Share Price rose 8.11% to Rs 160, but it does not establish a company-specific catalyst. The verified record only shows the day’s price action and turnover.

What is Speciality Medicines Share Price today?

Ans. Speciality Medicines Share Price today closed at Rs 160, compared with the previous close of Rs 148. The stock added Rs 12 during the session and finished at the day high.

What is the market capitalisation of Speciality Medicines Ltd.?

Ans. Speciality Medicines has a market capitalisation of Rs 129.59 crore. That is above the Trading sector median in the supplied benchmark set, but below the benchmark average. The company operates in the Trading sector.

What are the valuation ratios for Speciality Medicines Share Price analysis?

Ans. Speciality Medicines carries a P/E ratio of 9.98 and a P/B ratio of 1.83. Those figures place the stock below the sector median on P/E and above the median on P/B.

How do ROE and ROCE look for Speciality Medicines?

Ans. ROE is 37.85% and ROCE is 34.47%. Both are comfortably above the Trading sector medians in the supplied benchmark set and indicate strong return ratios in the latest data. ROE stands at 37.85%.

What do EPS, book value and dividend yield show?

Ans. EPS is Rs 14.83, book value is Rs 81.03 and dividend yield is 0. EPS measures earnings per share, book value shows accounting net worth per share, and the yield is currently nil.

How does Speciality Medicines compare with Trading sector peers?

Ans. Speciality Medicines Share Price is paired with a lower P/E than all listed peers and stronger ROE and ROCE than most of them. Its market cap is much smaller than the peer names supplied.